Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.36
Delayed Data
As of 4:00pm ET
 -0.02 / -1.45%
Today’s Change
0.67
Today|||52-Week Range
5.10
-57.28%
Year-to-Date

Today’s Trading

Previous close1.38
Today’s open1.35
Day’s range1.33 - 1.40
Volume1,014,767
Average volume (3 months)3,187,380
Market cap$139.4M
Dividend yield--
Data as of 4:00pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-163.97%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio0.9
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ADMPAdamis Pharmaceutica...-0.45-8.82%
OMEDOncoMed Pharmaceutic...-0.02-0.55%
AGRXAgile Therapeutics I...+0.44+8.92%
REPHRecro Pharma Inc0.000.00%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael E. Castagna
Chief Financial Officer &
Chief Accounting Officer
Steven Binder
Corporate headquarters
Valencia, California

Forecasts